Navigation Links
Ph.D. Peptide Display Cloning System from New England Biolabs

ProductsPh.D. Peptide Display Cloning System from New England Biolabs
Company New England Biolabs
Item Ph.D. Peptide Display Cloning System
Price 
Description The Ph.D. Peptide Display Cloning System facilitates the display of custom peptide libraries on the surface of bacteriophage M13 as coat protein fusions, creating a physical linkage between each displayed peptide and its encoding DNA sequence. Peptide ligands for a variety of targets can then be selected by the straightforward method of biopanning. The supplied display vector M13KE is an M13 derivative with cloning sites engineered for N-terminal pIII fusion, resulting in a valency of 5 displayed peptides per virion. The use of a phage vector, rather than a phagemid, simplifies the intermediate amplification steps, since neither antibiotic selection nor helper phage superinfection are required. Since displayed proteins longer than 20-30 amino acids have a deleterious effect on the infectivity function of pIII in phage vectors, this vector is suitable only for the display of short peptides. Included with the cloning vector is an insert extension primer as well as a detailed protocol for cloning a peptide libra
Info New England BiolabsNew England Biolabs
32 Tozer Rd.
Beverly, MA 01915-5599

Customer Service: 800-632-5227
Tech Support: 800-632-7799
Fax Number: 978-921-1350
Web Site: http://www.neb.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Ph.D.-12 Peptide 12-mer Library Kit from New England Biolabs
2. Ph.D.-C7C Disulfide Constrained Peptide Library Kit from New England Biolabs
3. Standard Protein Kinase Substrate (PKS) Peptide Microarray from LC Sciences
4. Peptide Design and Custom Synthesis from Global Peptide Services, LLC.
5. Protein Kinase Substrate (PKS) Peptide Microarray - Comprehensive Service from LC Sciences
6. Human and Mouse RAR Neutralizing Peptide from ABR-Affinity BioReagents
7. Epitope Peptide Microarray - Comprehensive Service from LC Sciences
8. Custom Peptide Microarray - Comprehensive Service from LC Sciences
9. Peptide Synthesis from Sigma-Genosys
10. Rat rab 3D Neutralizing Peptide from ABR-Affinity BioReagents
11. Rat SAP97 Neutralizing Peptide from ABR-Affinity BioReagents
Request Info...
Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, Xylene Cyanol, glycerol solution in TE...
Request Info...
Request Info...
Biology Products:
(Date:11/4/2014)... 5, 2014 – University of Utah engineers developed the ... jet fuel produce electricity without needing to ignite the ... power portable electronics, off-grid power and sensors. , A ... the American Chemical Society journal ACS Catalysis . ... chemical reaction between a fuel and an oxygen-rich source ...
(Date:11/4/2014)... 2014   3D ... Fuel3D , a developer of 3D scanning ... totaling $6.4 million (£4 million). This funding builds on the ... year and paves the way for the commercial launch of ... funding round was led by Chimera Partners and will be ...
(Date:11/3/2014)... 3, 2014  NeuroSigma ® , Inc. (NeuroSigma), ... company focused on commercialization of its non-invasive ... treatment of neurological and neuropsychiatric disorders, announced today ... issued a Notice of Allowance for Mexican Patent ... by NeuroSigma and the Regents of the University ...
Breaking Biology News(10 mins):Jet-fueled electricity at room temperature 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3
... CA Researchers from all over the world will be ... Department of Energy Joint Genome Institute 6th Annual Meeting, ... clean energy generation and the environment. Keynote speeches will ... Linear Accelerator Center, and microbial ecologist Terry Hazen of ...
... March 9, 2011 ActiveRx Rehabilitation , a ... working with senior adults, is now available to franchisees ... active aging. ActiveRx Development Company, Inc., based ... qualified operators interested in single or multi-location opportunities and ...
... - Hybrid plants with multiple genome copies show evidence of ... the genes of the other parent, even to the point ... Brian Dilkes, an assistant professor of genetics at Purdue University, ... California Davis and University of Southern California to study the ...
Cached Biology News:New Healthcare Franchise Opportunity Focuses on Treating Exploding Senior Population 2Study shows how plants sort and eliminate genes over millennia 2
(Date:11/21/2014)... SAN DIEGO , Nov. 20, 2014 /PRNewswire/ ... patient has been dosed in its Phase 1 ... and cisplatin for the treatment of malignant pleural ...  Polaris Group is conducting clinical trials on ADI-PEG ... other agents, for the treatment of several other ...
(Date:11/18/2014)... -- Cord Blood Registry® (CBR®) announces that the ... Stem Cell Summit, the largest global meeting of stem cell ... Summit will be held December 3-5 at the Marriott Rivercenter ... The World Stem Cell Summit aims to ... convening the most prominent figures in the field to share ...
(Date:11/18/2014)... Athena Signature Series: Turning Cancer ‘Off’ – featuring ... professor in the Regulatory Biology Laboratory at the Salk Institute, ... to an “off switch” for drug resistance in cancer. , ... research is making a global impact in the fight against ... host Cheryl K. Goodman, CEO of Social Global Mobile LLC, ...
(Date:11/18/2014)... 18, 2014 2014 Deep ... is professional and in-depth report on Polytetrahydrofuran ... information, including its definition, characterization, application, and ... This exploration covers the worldwide business investigation, ... examination covering macroeconomic environment & financial circumstance ...
Breaking Biology Technology:Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma 2Cord Blood Registry Sponsors 2014 World Stem Cell Summit 2Cord Blood Registry Sponsors 2014 World Stem Cell Summit 3PTMEG Market: 2019 Global Polytetrahydrofuran Industry Development Trends & Analysis Now at DeepResearchReports.com 2PTMEG Market: 2019 Global Polytetrahydrofuran Industry Development Trends & Analysis Now at DeepResearchReports.com 3